Blogs / News

Investing in the unlisted market can offer unique opportunities for investors looking to diversify their portfolio and potentially earn significant returns.

15 May, 2023,

25 0

Janus Henderson Marks Down Pharmeasy's Valuation by Half to $2.8Bn

Global Investors Mark Down PharmEasy Valuation Amid Financial Struggles and Broader Tech Downturn 1. Markdown in PharmEasy's Valuation: According to regulatory filings with the US Securities and Excha...

19 Oct, 2022,

160 0

Excerpts from the Interview of Co-founder of Pharmeasy with Times Now.

Ques. Why have you decided to not go ahead with the IPO? I think there are a couple of factors first and foremost, I think the companies on a very different and rapidly evolving trajectory while our...

22 Sep, 2022, News

100 0

Pharmeasy Right Issue at Rs.100 opening from 21.09.2022. Should You Apply?

Basic Details API holding, the parent company of Pharmeasy, is going to conduct the rights issue to raise funds and strengthen the valuation of the company amid weak market conditions. 1. As per the...

11 Nov, 2021, News

131 0

Pharmeasy parent API Holdings filed DRHP for Rs 6250 crore IPO

PharmEasy, a leading name in India's e-pharmacy sector, has recently made a significant move towards its growth trajectory by filing for an Initial Public Offering (IPO). API Holdings, PharmEasy's par...